MedPath

Heterogeneity and Development of Early COPD

Recruiting
Conditions
Chronic Obstructive Pulmonary Disease
Registration Number
NCT06096285
Lead Sponsor
China-Japan Friendship Hospital
Brief Summary

This study aims to investigate the clinical characteristics and heterogeneities of early chronic obstructive pulmonary disease (COPD), to determine the disease development of early COPD, and to establish a multidimensional model for predicting the outcomes of early COPD.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
84
Inclusion Criteria
  • The individuals who meet the defining criteria of PRISm, COPD Stage 0, Pre-COPD, Early COPD, Young COPD, and Mild COPD, according to the latest GOLD documents and publications.
Exclusion Criteria
  • Age < 18 years or > 80 years;
  • Pregnant or maternal women;
  • Having malignant and active tumor(s), and receiving treatment;
  • Undergoing a surgical operation;
  • Having problems with mental awareness;
  • Having difficulties in daily activities;
  • Participating in other interventional clinical trials.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of participants with COPD exacerbationOne year

COPD exacerbation refers to acute deterioration of respiratory symptoms (e.g. cough, sputum, wheeze, dyspnea), especially resulting in hospital visit or admission.

Secondary Outcome Measures
NameTimeMethod
FVC% predicted valueOne year
FVCOne year
FEV1One year
FEV1% predicted valueOne year
The COPD Assessment Test scaleOne year

The COPD Assessment Test scores range from 0 to 40, with higher scores indicating worse symptoms.

FEV1/FVC ratioOne year
The modified Medical Research Council dyspnea scaleOne year

The modified Medical Research Council dyspnea scores range from 0 to 4, with higher scores indicating more severe dyspnea.

Trial Locations

Locations (1)

China-Japan Friendship Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath